Professor, Pediatrics, Tufts Medical Center
Neonat/Perinatology
Dr. Diana W. Bianchi, MD
|
|
Give Review
Doctor Diana W. Bianchi, MD is an expert in the field of Neonat/Perinatology. She graduated from Stanford University School of Medicine. Stanford University School of Medicine is a top medical college. Stanford University School of Medicine is ranked 2/25 in Research/PrimaryCare. She received 2 awards: "America's Top Doctors" and "Boston Magazine". Diana Bianchi is also published. She has 102 publications published. The lastest publication: "Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.'
Publications
- The Pathway Not Taken: Understanding 'Omics Data in the Perinatal Context.
- Fetal sex chromosome testing by maternal plasma DNA sequencing: clinical laboratory experience and biology.
- The Amniotic Fluid Transcriptome as a Guide to Understanding Fetal Disease.
- CSAX: Characterizing Systematic Anomalies in eXpression Data.
- MENDEL: Morphologist and Mathematician Founder of Genetics - To Begin a Celebration of the 2015 Sesquicentennial of Mendel's Presentation in 1865 of his Versuche über ...
- Analysis of Adult Cerebral Cortex and Hippocampus Transcriptomes Reveals Unique Molecular Changes in the Ts1Cje Mouse Model of Down Syndrome.
- RNA-Seq and expression microarray highlight different aspects of the fetal amniotic fluid transcriptome.
- Amniotic fluid RNA gene expression profiling provides insights into the phenotype of Turner syndrome.
- Antenatal Noninvasive DNA Testing: Clinical Experience and Impact.
- Prenatal treatment of Down syndrome: a reality?
- DNA sequencing versus standard prenatal aneuploidy screening.
- In case you missed it: the Prenatal Diagnosis section editors bring you the most significant advances of 2013.
- Review: Cell-free fetal DNA in the maternal circulation as an indication of placental health and disease.
- Current controversies in prenatal diagnosis 1: Should Non-invasive DNA Testing (NIDT) be the standard screening test for Down syndrome in all pregnant women?
- Global gene expression analysis of amniotic fluid cell-free RNA from recipient twins with twin-twin transfusion syndrome.
- The role of social networking sites in medical genetics research.
- Massively Parallel Sequencing of Maternal Plasma DNA in 113 Cases of Fetal Nuchal Cystic Hygroma.
- Noninvasive prenatal testing creates an opportunity for antenatal treatment of down syndrome.
- Chorionic plate expression patterns of the maspin tumor suppressor protein in preeclamptic and egg donor placentas.
- Performing discovery-driven neonatal research by transcriptomic analysis of routinely discarded biofluids.
- From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.
- The natural history of fetal cells in postpartum murine maternal lung and bone marrow: A two-stage phenomenon.
- Fetal cell microchimerism in the maternal heart: baby gives back.
- The amniotic fluid transcriptome: a source of novel information about human fetal development.
- Increased incidence of pregnancy complications in women who later develop scleroderma: a case control study.
- Fetal Cells in the Murine Maternal Lung Have Well-Defined Characteristics and Are Preferentially Located in Alveolar Septum.
- Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.
- Proof of concept study to assess fetal gene expression in amniotic fluid by nanoarray PCR.
- Optimal Techniques for mRNA Extraction from Neonatal Salivary Supernatant.
- Maternal background strain influences fetal-maternal trafficking more than maternal immune competence in mice.
- Prenatal pharmacotherapy for fetal anomalies: a 2011 update.
- Cell Plasticity in lung injury and repair: report from an NHLBI workshop, April 19-20, 2010.
- Gene expression analysis of amniotic fluid: new biomarkers and novel antenatal treatments.
- Lessons learned from the introduction of personalized genotyping into a medical school curriculum.
- Fetal cell microchimerism and cancer: a nexus of reproduction, immunology, and tumor biology.
- Cord blood genomic analysis highlights the role of redox balance.
- Relationships between cell-free DNA and serum analytes in the first and second trimesters of pregnancy.
- Increased fetal cell trafficking in murine lung following complete pregnancy loss from exposure to lipopolysaccharide.
- Neonatal salivary analysis reveals global developmental gene expression changes in the premature infant.
- Placental pathology in egg donor pregnancies.
- High-Throughput Discovery and Characterization of Fetal Protein Trafficking in the Blood of Pregnant Women.
- Fetal cells in the pregnant mouse are diverse and express a variety of progenitor and differentiated cell markers.
- Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses.
- Microchimerism in endocrine pathology.
- Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung.
- Cell-free DNA fragmentation patterns in amniotic fluid identify genetic abnormalities and changes due to storage.
- pH but not hypoxia affects neonatal gene expression: relevance for housekeeping gene selection.
- Maternal thyroid hypofunction and pregnancy outcome.
- Murine maternal cell microchimerism: analysis using real-time PCR and in vivo imaging.
- Quantification of green fluorescent protein by in vivo imaging, PCR, and flow cytometry: comparison of transgenic strains and relevance for fetal cell microchimerism.
- Reproductive issues for adults with autosomal dominant polycystic kidney disease.
- Method for extraction of high-quantity and -quality cell-free DNA from amniotic fluid.
- Gene expression analysis in pregnant women and their infants identifies unique fetal biomarkers that circulate in maternal blood.
- Short-term clearance of cell-free nucleic acids after first-trimester termination of pregnancy.
- The contribution of birth defects to preterm birth and low birth weight.
- Spot counting to locate fetal cells in maternal blood and tissue: a comparison of manual and automated microscopy.
- Fetomaternal cell trafficking and the stem cell debate: gender matters.
- Cell-free fetal DNA in amniotic fluid: unique fragmentation signatures in euploid and aneuploid fetuses.
- Prenatal diagnosis using cell-free nucleic acids in maternal body fluids: a decade of progress.
- Nuchal translucency and the risk of congenital heart disease.
- Robert E. Gross Lecture. Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy.
- Cell-free fetal DNA plasma extraction and real-time polymerase chain reaction quantification.
- Will epigenetic allelic ratio analysis turn prenatal diagnosis of trisomy 18 on its EAR?
- Fetal nucleic acids in maternal body fluids: an update.
- Trophoblastic oxidative stress and the release of cell-free feto-placental DNA.
- Circulating cell-free fetal messenger RNA levels after fetoscopic interventions of complicated pregnancies.
- The natural history of trisomy 12p.
- Sharpening the tools: a summary of a National Institutes of Health workshop on new technologies for detection of fetal cells in maternal blood for early prenatal diagn...
- At-home fetal DNA gender testing: caveat emptor.
- Larger columns and change of lysis buffer increase the yield of cell-free DNA extracted from amniotic fluid.
- Fetal therapy for single gene disorders.
- Assisted reproductive technology and pregnancy outcome.
- Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.
- High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery.
- Placental volume, as measured by 3-dimensional sonography and levels of maternal plasma cell-free fetal DNA.
- Presence of filterable and nonfilterable cell-free mRNA in amniotic fluid.
- Global gene expression analysis of the living human fetus using cell-free messenger RNA in amniotic fluid.
- Persistent elevation of cell-free fetal DNA levels in maternal plasma after selective laser coagulation of chorionic plate anastomoses in severe midgestational twin-tw...
- Changes of cell-free fetal DNA in maternal plasma after elective termination of pregnancy.
- Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels.
- Microarray analysis of cell-free fetal DNA in amniotic fluid: a prenatal molecular karyotype.
- Transfer of fetal cells with multilineage potential to maternal tissue.
- Circulating cell-free fetal nucleic acid analysis may be a novel marker of fetomaternal hemorrhage after elective first-trimester termination of pregnancy.
- Fetal cell-free nucleic acids in the maternal circulation: new clinical applications.
- Plasma gamma-globin gene expression suggests that fetal hematopoietic cells contribute to the pool of circulating cell-free fetal nucleic acids during pregnancy.
- Cell-free fetal DNA in the cerebrospinal fluid of women during the peripartum period.
- Cell-free fetal DNA levels in maternal plasma after elective first-trimester termination of pregnancy.
- Interlaboratory comparison of fetal male DNA detection from common maternal plasma samples by real-time PCR.
- Two-stage elevation of cell-free fetal DNA in maternal sera before onset of preeclampsia.
- The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review.
- Cervical cancer and microchimerism.
- Evaluation of cell-free fetal DNA as a second-trimester maternal serum marker of Down syndrome pregnancy.
- Combined FISH and immunolabeling on paraffin-embedded tissue sections for the study of microchimerism.
- Fetal cell-free plasma DNA concentrations in maternal blood are stable 24 hours after collection: analysis of first- and third-trimester samples.
- Maternal cell microchimerism in newborn tissues.
- Significant fetal cell microchimerism in a nontransfused woman with hepatitis C: Evidence of long-term survival and expansion.
- Down syndrome and cell-free fetal DNA in archived maternal serum.
- Prenatal diagnosis of acro-dermatoungual-lacrimal-tooth syndrome, a dominantly inherited ectrodactyly.
- Chimerism of the transplanted heart.
- Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
- Assessing the fetal effects of maternal obesity via transcriptomic analysis of cord blood: a prospective case-control study.
Schools
Stanford University
Children39s Hospital Boston
Doctors Specialties
- Neonatal Medicine
- Neonat/Perinatology
Accepted Insurances
Awards
- America's Top Doctors
- Boston Magazine
Education
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Stanford University School of Medicine
Hospital
-
Tufts Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Robert L. Ursprung, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ceara C. McNiff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stella Kourembanas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard E. Wilker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine A. Rottkamp, MD |
|
|
Dr. Timmy Ho, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camilia R. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy R. Levingston, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dewayne M. Pursley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen R. McAlmon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mayya Geha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julie A. Bartholomew, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maricor Cristina C. Javier, MD |
|
|
Dr. Natalia Henner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wanda D. Barfield, MD
This Doctor is OpenDoctor Recommended.
|